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Introduction
In the situation of acute coronary occlusion, the myocar-
dium supplied by the occluded vessel is subject to
ischemia and is referred to as the myocardium at risk
(MaR). It has previously been shown that cardiac mag-
netic resonance (CMR) imaging can be used for the assess-
ment of MaR employing a T2-weighted edema sequence.
Recently, it has been suggested that the endocardial extent
of hyperenhancement as assessed by contrast enhanced
CMR can also be used to quantify the MaR.
Purpose
We sought to assess the ability of endocardial extent by
contrast enhanced CMR to quantify MaR in relation to T2-
weighted edema imaging.
Methods
Thirty-six patients with early reperfused first-time ST-seg-
ment elevation myocardial infarction underwent CMR
imaging within 7 days after percutaneous coronary inter-
vention. The MaR was determined by contrast enhanced
endocardial extent and compared to the MaR as deter-
mined by T2-weighted edema imaging.
Results
The MaR was 34 ± 10% (range 16-59) and 24 ± 12%
(range 0-66) of the left ventricle by T2-weighted edema
imaging and contrast enhanced endocardial extent,
respectively. Comparison of the two methods yielded a
weak correlation (r2 = 0.26, p = 0.002) with a bias of -10
± 11% (Figure 1). The MaR was consistently larger than
the final infarct size (14 ± 10%, range 0-47), which
resulted in a myocardial salvage of 57 ± 21% (range 12-
100).
Conclusion
This study demonstrated that the endocardial extent as
assessed by contrast enhanced CMR is not an accurate
method for the assessment of MaR in patients with early
reperfusion, using T2-weighted edema imaging as refer-
ence method.
from 13th Annual SCMR Scientific Sessions
Phoenix, AZ, USA. 21-24 January 2010
Published: 21 January 2010
Journal of Cardiovascular Magnetic Resonance 2010, 12(Suppl 1):P173 doi:10.1186/1532-429X-12-S1-P173
<supplement> <title> <p>Abstracts of the 13<sup>th </sup>Annual SCMR Scientific Sessions - 2010</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1532-429X-11-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/files/pdf/1532-429X-11-S1-info</url> </supplement>
This abstract is available from: http://jcmr-online.com/content/12/S1/P173
© 2010 Ubachs et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
Journal of Cardiovascular Magnetic Resonance 2010, 12(Suppl 1):P173 http://jcmr-online.com/content/12/S1/P173Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Agreement between contrast enhanced endocardial extent and T2-weighted CMRFigure 1
Agreement between contrast enhanced endocardial extent and T2-weighted CMR. (A) The MaR determined by 
contrast enhanced endocardial extent versus the MaR as determind by T2-weighted CMR. Solid line+ of identity; dashed line = 
regression line. (B) Bland-Altman graph showing the difference between contrast enhanced endocardial extent and T2-
weighted CMR. Soldid line = mean difference; dashed lines = ± 2SD. Patients with an aborted infraction of myocardial salvage 
over 90% are presented as encircled dots.Page 2 of 2
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